BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 2497971)

  • 1. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
    Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
    Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
    Kerangueven F; Sempere C; Tabilio A; Mannoni P
    Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
    Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
    Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cells.
    Craig RW; Buchan HL
    J Cell Physiol; 1989 Oct; 141(1):46-52. PubMed ID: 2506196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
    Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
    Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combinations of transforming growth factor-beta 1 and tumor necrosis factor on induction of differentiation of human myelogenous leukemic cell lines.
    Kamijo R; Takeda K; Nagumo M; Konno K
    J Immunol; 1990 Feb; 144(4):1311-6. PubMed ID: 2105994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
    Bendall LJ; Kortlepel K; Gottlieb DJ
    Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia.
    Kamińska T; Hus I; Dmoszyńska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 2():S83-7. PubMed ID: 11665752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-alpha and interferon-gamma.
    Jo T; Tomiyama T; Ohashi K; Saji F; Tanizawa O; Ozaki M; Yamamoto R; Yamamoto T; Nishizawa Y; Terada N
    Anat Rec; 1995 Jan; 241(1):70-6. PubMed ID: 7879925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase.
    Beran M; Pisa P; O'Brien S; Kurzrock R; Siciliano M; Cork A; Andersson BS; Kohli V; Kantarjian H
    Cancer Res; 1993 Aug; 53(15):3603-10. PubMed ID: 8339266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile chronic myelogenous leukemia multilineage CD34+ cells: aberrant growth and differentiation properties.
    Freedman MH; Hitzler JK; Bunin N; Grunberger T; Squire J
    Stem Cells; 1996 Nov; 14(6):690-701. PubMed ID: 8948026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of gamma-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells.
    Ponzoni M; Casalaro A; Lanciotti M; Montaldo PG; Cornaglia-Ferraris P
    Cancer Res; 1992 Feb; 52(4):931-9. PubMed ID: 1371090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.